18 -7 (81) 2025 - Artikova S.G., Haydarova N.B. - EXAMINATION AND MANAGEMENT OF PATIENTS WITH METABOLIC-RELATED FATTY LIVER DISEASE

EXAMINATION AND MANAGEMENT OF PATIENTS WITH METABOLIC-RELATED FATTY LIVER DISEASE

Artikova S.G. - Andijan State Medical Institute

Haydarova N.B. - Andijan State Medical Institute

Dauletbayev B.K. - Andijan State Medical Institute

Valiyeva Z.S. - Andijan State Medical Institute

Resume

The main pathogenetic mechanisms of the development of non-alcoholic steatohepatitis and alcohol-associated liver lesions, the central element of which is the accumulation of lipids in hepatocytes and increased free radical lipid oxidation reactions, which leads to necrosis of liver cells, have been studied. Current approaches to the treatment of fatty changes and steatohepatitis are discussed. The significant role of a-lipoic acid (thioctic acid) in the regulation of metabolic processes in the liver is emphasized, which makes its use in therapeutic strategies for the treatment of alcoholic and non-alcoholic metabolic liver diseases an extremely promising direction.

Key words: metabolically associated fatty liver disease.

First page

86

Last page

88

For citation:Artikova S.G., Haydarova N.B., Dauletbayev B.K., Valiyeva Z.S. - EXAMINATION AND MANAGEMENT OF PATIENTS WITH METABOLIC-RELATED FATTY LIVER DISEASE//New Day in Medicine 7(81)2025 86-88 https://newdayworldmedicine.com/en/new_day_medicine/7-81-2025

List of References

1. Алдашева Ж.А., Ивакин В.М., Джумабеков А.Т. Особенности морфологической картины печени у больных с различными формами неалкогольной жировой болезни печени // Пробл. ГАЭЛ. 2013;4:9-14.
2. Барановский А.Ю., Райхельсон К.Л., Марченко Н.В. Применение S-аденозилметионина (Гептрала®) в терапии больных неалкогольным стеатогепатитом // Клинические перспективы гастроэнтерологии, гепатологии. 2010;1:3-10.
3. Мансуров Х.Х., Мироджов Г.К., Мансурова Ф.Х., Дустов А.Д., Мирзоева П.Ф., Мутихова Х.Ш. Инсулинрезистентность у больных метаболическим синдромом и желчнокаменной болезнью. // Клинич. медицина. 2005;7:103-108.
4. Суплотова Л.А., Кульмаметова Д.С., Федорова А.И., Душина Т.С., Макарова О.Б. Влияние ингибиторов натрий-глюкозного котранспортера 2-го типа на неалкогольную жировую болезнь печени // Медицинский совет. 2022;15:83-89.
5. Bull F. C., Al-Ansari S. S., Biddle S., Borodulin K., Buman M. P., Cardon G., Carty C., Chaput J.-P., Chastin S., Chou R., et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour // Br. J. Sports Med. 2020;54:1451-1462.
6. Slomko J., Zalewska M., Niemiro W., Kujawski S., Slupski M., Januszko-Giergielewicz B., Zawadka-Kunikowska M., Newton J., Hodges L., Kubica J., et al. Evidence-Based Aerobic Exercise Training in Metabolic-Associated Fatty Liver Disease: Systematic Review with Meta-Analysis // J. Clin. Med. 2021;10:16-59.

   file

   download